Characteristics | uOR | 95% CI | aOR | 95% CI | p value* |
---|---|---|---|---|---|
Pre-existing chronic conditions | Ìý | Ìý | Ìý | Ìý | Ìý |
 chronic lung disease | 2.92 | (2.02, 4.20) | 1.55 | (0.97, 2.46) | 0.064 |
 sleep apnea | 1.57 | (1.21, 2.03) | 0.92 | (0.65, 1.30) | 0.631 |
 a²õ³Ù³ó³¾²¹ | 1.83 | (1.44, 2.33) | 1.12 | (0.83, 1.50) | 0.469 |
 chronic heart disease | 1.43 | (0.93, 2.20) | 0.82 | (0.50, 1.35) | 0.441 |
 d¾±²¹²ú±ð³Ù±ð²õ | 1.75 | (1.34, 2.28) | 1.15 | (0.84, 1.59) | 0.383 |
 chronic kidney disease | 0.65 | (0.31, 1.38) | 0.38 | (0.15, 0.92) | 0.032 |
 high blood pressure | 1.70 | (1.40, 2.06) | 1.17 | (0.88, 1.55) | 0.275 |
 chronic blood disorder | 1.74 | (0.87, 3.46) | 0.80 | (0.34, 1.88) | 0.609 |
 o²õ³Ù±ð´Ç±è´Ç°ù´Ç²õ¾±²õ | 1.68 | (1.13, 2.49) | 0.83 | (0.51, 1.34) | 0.443 |
 back problems | 2.10 | (1.73, 2.55) | 1.20 | (0.88, 1.63) | 0.247 |
 urinary incontinence | 1.42 | (0.94, 2.16) | 0.74 | (0.47, 1.18) | 0.211 |
 bowel disorder | 2.20 | (1.66, 2.92) | 1.17 | (0.83, 1.64) | 0.374 |
 weakened immune system | 2.62 | (1.93, 3.56) | 1.40 | (0.94, 2.10) | 0.098 |
 chronic neurological disorder | 2.23 | (1.44, 3.44) | 1.11 | (0.63, 1.93) | 0.724 |
 chronic fatigue syndrome or fibromyalgia | 4.88 | (3.18, 7.47) | 2.09 | (1.23, 3.53) | 0.006 |
 s³Ù°ù´Ç°ì±ð | 1.20 | (0.57, 2.50) | 0.56 | (0.25, 1.25) | 0.157 |
 mental health condition | 1.93 | (1.61, 2.32) | 1.15 | (0.86, 1.53) | 0.343 |
 a°ù³Ù³ó°ù¾±³Ù¾±²õ | 2.13 | (1.77, 2.57) | 1.14 | (0.84, 1.54) | 0.402 |
Age at infection (ref = 15–34) | - | - | - | - | 0.481 |
 35–49 | 1.11 | (0.92, 1.33) | 1.06 | (0.87, 1.29) | 0.593 |
 50–64 | 1.29 | (1.06, 1.56) | 0.98 | (0.78, 1.23) | 0.842 |
 65+ | 1.18 | (0.94, 1.48) | 0.85 | (0.62, 1.15) | 0.280 |
Sex (ref = male) | - | - | - | - | - |
 f±ð³¾²¹±ô±ð | 1.33 | (1.16, 1.56) | Interaction | - | - |
Number of pre-existing chronic health conditions (ref = 0) | - | - | - | - | 0.013 |
 1 | 1.35 | (1.11, 1.63) | 1.10 | (0.85, 1.42) | 0.475 |
 2 | 2.62 | (2.10, 3.28) | 1.72 | (1.13, 2.61) | 0.011 |
 3 | 2.50 | (1.92, 3.27) | 1.34 | (0.76, 2.35) | 0.314 |
 &²µ³Ù; 3 | 3.48 | (2.74, 4.43) | 1.28 | (0.55, 2.98) | 0.565 |
Ethno-cultural composition (ref = first quintile)b | - | - | - | - | 0.014 |
 s±ð³¦´Ç²Ô»å | 1.38 | (1.08, 1.75) | 1.32 | (1.02, 1.71) | 0.036 |
 t³ó¾±°ù»å | 1.12 | (0.89, 1.41) | 1.11 | (0.85, 1.44) | 0.435 |
 f´Ç³Ü°ù³Ù³ó | 1.16 | (0.92, 1.47) | 1.26 | (0.97, 1.63) | 0.089 |
 fifth (highest) | 1.27 | (0.97, 1.65) | 1.35 | (1.00, 1.82) | 0.047 |
 u²Ô°ì²Ô´Ç·É²Ô | 1.47 | (1.11, 1.95) | 1.71 | (1.25, 2.35) | 0.001 |
Region of residence (ref = Ontario) | - | - | - | - | 0.012 |
 British Columbia | 1.14 | (0.92, 1.41) | 1.10 | (0.88, 1.39) | 0.408 |
 P°ù²¹¾±°ù¾±±ð²õ | 0.89 | (0.73, 1.09) | 0.75 | (0.60, 0.94) | 0.011 |
 Q³Ü±ð²ú±ð³¦ | 0.77 | (0.63, 0.94) | 0.89 | (0.71, 1.11) | 0.289 |
 Atlantic Canada | 0.95 | (0.78, 1.15) | 0.97 | (0.77, 1.21) | 0.768 |
Body mass index (BMI) (ref = underweight and normal weight (BMI < 25Ìýkg/m2)) | - | - | - | - | - |
 o±¹±ð°ù·É±ð¾±²µ³ó³ÙÌý (25Ìýkg/m2 < = BMI < 30Ìýkg/m2) | 1.00 | (0.83, 1.21) | Interaction | - | - |
 o²ú±ð²õ±ð (BMI > = 30Ìýkg/m2) | 1.63 | (1.35, 1.98) | Interaction | - | - |
 u²Ô°ì²Ô´Ç·É²Ô | 1.22 | (0.69, 2.18) | Interaction | - | - |
Pre-existing chronic health symptoms | Ìý | Ìý | Ìý | Ìý | Ìý |
 loss of appetite | 3.63 | (2.33, 5.63) | 2.13 | (1.31, 3.46) | 0.002 |
Number of pre-existing chronic health symptoms (ref = 0) | - | - | - | - | &±ô³Ù; 0.001 |
 1 or 2 | 1.51 | (1.25, 1.83) | 1.37 | (1.12, 1.67) | 0.002 |
 3 | 1.87 | (1.44, 2.43) | 1.62 | (1.21, 2.16) | 0.001 |
 &²µ³Ù; 3 | 2.86 | (2.39, 3.43) | 1.87 | (1.45, 2.39) | &±ô³Ù; 0.001 |
Months since last vaccine dose prior to the month of infection (ref= <=3 months) | Ìý | Ìý | Ìý | Ìý | &±ô³Ù; 0.001 |
 Not vaccinated | 2.73 | (2.22, 3.34) | 1.76 | (1.31, 2.37) | &±ô³Ù; 0.001 |
 4–6 months | 1.19 | (0.96, 1.47) | 1.29 | (1.04, 1.61) | 0.019 |
 > 6 months | 1.52 | (1.17, 1.97) | 1.67 | (1.27, 2.19) | &±ô³Ù; 0.001 |
 U²Ô°ì²Ô´Ç·É²Ô | 1.60 | (0.95, 2.71) | 1.28 | (0.75, 2.19) | 0.362 |
Time period of first infection (ref = pre-omicron) | - | - | - | - | &±ô³Ù; 0.001 |
 OmicronÌý (December 1, 2021 – date of electronic questionnaire completion) | 0.41 | (0.35, 0.48) | 0.50 | (0.38, 0.66) | &±ô³Ù; 0.001 |
 u²Ô°ì²Ô´Ç·É²Ô | 1.48 | (0.56, 3.87) | 1.95 | (0.68, 5.54) | 0.212 |
Interaction between sex and BMI | - | - | - | - | 0.003 |
 male (ref = underweight or normal weight) | - | - | - | - | - |
 o±¹±ð°ù·É±ð¾±²µ³ó³Ù | - | - | 1.27 | (0.89, 1.81) | 0.183 |
 o²ú±ð²õ±ð | - | - | 2.21 | (1.54, 3.18) | &±ô³Ù; 0.001 |
 u²Ô°ì²Ô´Ç·É²Ô | Ìý | Ìý | 2.88 | (0.15, 53.63) | 0.478 |
female (ref = underweight or normal weight) | - | - | - | - | - |
 o±¹±ð°ù·É±ð¾±²µ³ó³Ù | - | - | 0.92 | (0.71, 1.21) | 0.562 |
 o²ú±ð²õ±ð | - | - | 1.02 | (0.80, 1.31) | 0.848 |
 u²Ô°ì²Ô´Ç·É²Ô | Ìý | Ìý | 0.73 | (0.38, 1.40) | 0.346 |
 f±ð³¾²¹±ô±ð underweight or normal weight (ref = male underweight or normal weight) | - | - | 1.81 | (1.27, 2.56) | 0.001 |
 f±ð³¾²¹±ô±ð overweight (ref = male overweight) | - | - | 1.31 | (1.00, 1.72) | 0.051 |
 f±ð³¾²¹±ô±ð obese (ref = male obese) | - | - | 0.84 | (0.64, 1.09) | 0.180 |
 f±ð³¾²¹±ô±ð unknown (ref = male unknown) | - | - | 0.46 | (0.02, 8.96) | 0.607 |